Procter & Gamble Health Q1 Results Live : Procter & Gamble Health declared their Q1 results on November 4, 2024, showcasing a topline increase of 2.78% year-over-year, with profits soaring by 25.56%. This quarter’s performance marks a significant improvement over the previous quarter, where revenue grew by 10.4% and profits surged by an astonishing 390.64%.
The company reported a decline in Selling, General & Administrative expenses, which fell by 4.96% quarter-over-quarter and decreased by 23.78% year-over-year, contributing to the enhanced profitability. This efficient cost management has allowed Procter & Gamble Health to bolster their operating income, which saw a remarkable increase of 418.04% sequentially and 31.75% on a year-over-year basis.
Earnings per share (EPS) for Q1 was reported at ₹49.6, representing a year-over-year increase of 25.57%. This solid EPS growth underscores the company’s robust financial health and operational efficiency.
In terms of stock performance, Procter & Gamble Health has delivered impressive returns of 10.59% in the last week, 16.75% over the past six months, and 15.19% year-to-date, indicating strong investor confidence in the company’s growth trajectory.
Currently, Procter & Gamble Health boasts a market capitalization of ₹9202.78 crore, with its stock trading within a 52-week range of ₹5742.4 at its high and ₹4636.55 at its low, reflecting a stable outlook amid market fluctuations.
Procter & Gamble Health Financials
| Period | Q1 | Q4 | Q-o-Q Growth | Q1 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 313.41 | 283.88 | +10.4% | 304.93 | +2.78% |
| Selling/ General/ Admin Expenses Total | 46.22 | 48.63 | -4.96% | 60.64 | -23.78% |
| Depreciation/ Amortization | 5.77 | 7.16 | -19.41% | 6.48 | -10.96% |
| Total Operating Expense | 205.14 | 262.98 | -21.99% | 222.75 | -7.91% |
| Operating Income | 108.27 | 20.9 | +418.04% | 82.18 | +31.75% |
| Net Income Before Taxes | 111.4 | 22.83 | +387.95% | 88.05 | +26.52% |
| Net Income | 82.33 | 16.78 | +390.64% | 65.57 | +25.56% |
| Diluted Normalized EPS | 49.6 | 19.05 | +160.36% | 39.5 | +25.57% |
